Anne-Paula De Sousa Delgado

Title: **Inventor Spotlight: Anne-Paula De Sousa Delgado**

Introduction

Anne-Paula De Sousa Delgado is an accomplished inventor based in Moilins de Rei, Spain. With a keen focus on advancements in polymer technology, she holds two notable patents that contribute to the fields of pharmaceutical formulations and polymer chemistry. Her innovative approaches have paved the way for more efficient drug delivery systems and catalytic processes.

Latest Patents

Anne-Paula's most recent patent is titled "Sustained release formulations comprising very low molecular weight polymers." This invention involves a parenteral, sustained, and controlled release, semisolid formulation that includes an end-capped oligomer and at least one active substance, all without the need for supplementary viscosity-reducing agents or excipients. Her second patent, "Catalytic systems for the ring-opening (co)polymerization of lactones," explores a groundbreaking system composed of a base and a sulphonamide, utilized as a catalyst for the ring-opening (co)polymerization of lactones. This invention also introduces novel sulphonamides and outlines a process that leverages the catalytic system effectively.

Career Highlights

Anne-Paula is associated with Ipsen Pharma S.a.s., where her contributions in research and development play a crucial role in driving the company's innovations forward. Her work primarily revolves around enhancing drug formulation and improving manufacturing processes, solidifying her reputation within the pharmaceutical industry.

Collaborations

Throughout her career, Anne-Paula has collaborated with notable colleagues, including Roland Cherif-Cheikh and Didier Bourissou. These partnerships have enabled her to explore new ideas and refine her inventions, fostering a collaborative environment that thrives on innovation.

Conclusion

In summary, Anne-Paula De Sousa Delgado exemplifies excellence in invention, contributing significantly to advancements in polymer formulations and catalytic processes. Her work not only impacts pharmaceutical developments but also enhances the efficiency of various biomedical applications. With her continued efforts, Anne-Paula is poised to remain at the forefront of innovative solutions in her field.